Castle Biosciences, Inc.CSTLNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 63 | 94↑50.2% | 137↑45.7% | 220↑60.4% | 332↑51.1% |
| Gross Profit | 53 | 78↑47.8% | 105↑34.2% | 175↑66.4% | 272↑55.5% |
| Operating Income | -7 | -40↓512.6% | -73↓81.8% | -68↑6.7% | 9↑112.8% |
| Net Income | -10 | -31↓204.3% | -67↓114.6% | -57↑14.4% | 18↑131.7% |
| EBITDA | -7 | -37↓416.0% | -58↓59.4% | -45↑22.8% | 38↑184.7% |
| EPS Diluted | -0.54 | -1.24↓129.6% | -2.58↓108.1% | -2.14↑17.1% | 0.62↑129.0% |